Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Ropert

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Targeted Oncology|November 18, 2011
Posterior reversible encephalopathy syndrome induced by anti-VEGF agentsCamille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Frontiers in Surgery|September 27, 2024
Robotic thoracic surgery: lessons learned from the first 1,000 proceduresMarion Durand, Lee S Nguyen, Frankie Mbadinga, et al.
Investigational New Drugs|September 30, 2010
Treatment of bevacizumab-induced hypertension by amlodipineOlivier Mir, Romain Coriat, Stanislas Ropert, et al.
Investigational New Drugs|June 5, 2010
Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinibRomain Coriat, Stanislas Ropert, Olivier Mir, et al.
Investigational New Drugs|August 28, 2010
Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patientsRomain Coriat, Olivier Mir, Anatole Cessot, et al.
International Journal of Nanomedicine|December 7, 2016
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I studyRomain Coriat, Sandrine J Faivre, Olivier Mir, et al.
Cancer Chemotherapy and Pharmacology|February 16, 2010
Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcomaOlivier Mir, Stanislas Ropert, Antoine Babinet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 4, 2009
Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasmaBenoit Blanchet, Carole Saboureau, Anne Sophie Benichou, et al.
Investigational New Drugs|August 14, 2010
Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinomaCharline Gomo, Romain Coriat, Lionel Faivre, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2009
Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patientsRomain Coriat, Olivier Mir, Sandra Camps, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Targeted Oncology|November 18, 2011
Posterior reversible encephalopathy syndrome induced by anti-VEGF agentsCamille Tlemsani, Olivier Mir, Pascaline Boudou-Rouquette, et al.
Frontiers in Surgery|September 27, 2024
Robotic thoracic surgery: lessons learned from the first 1,000 proceduresMarion Durand, Lee S Nguyen, Frankie Mbadinga, et al.
Investigational New Drugs|September 30, 2010
Treatment of bevacizumab-induced hypertension by amlodipineOlivier Mir, Romain Coriat, Stanislas Ropert, et al.
Investigational New Drugs|June 5, 2010
Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinibRomain Coriat, Stanislas Ropert, Olivier Mir, et al.
Investigational New Drugs|August 28, 2010
Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patientsRomain Coriat, Olivier Mir, Anatole Cessot, et al.
International Journal of Nanomedicine|December 7, 2016
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I studyRomain Coriat, Sandrine J Faivre, Olivier Mir, et al.
Cancer Chemotherapy and Pharmacology|February 16, 2010
Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcomaOlivier Mir, Stanislas Ropert, Antoine Babinet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 4, 2009
Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasmaBenoit Blanchet, Carole Saboureau, Anne Sophie Benichou, et al.
Investigational New Drugs|August 14, 2010
Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinomaCharline Gomo, Romain Coriat, Lionel Faivre, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2009
Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patientsRomain Coriat, Olivier Mir, Sandra Camps, et al.
Pageof 6